Mitsubishi Tanabe Pharma Product Pipeline Review 2012

Mitsubishi Tanabe Pharma Product Pipeline Review 2012 provides data on the Mitsubishi Tanabe Pharma Corporation’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Scope

- Mitsubishi Tanabe Pharma Corporation - Brief Mitsubishi Tanabe Pharma Corporation overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Mitsubishi Tanabe Pharma Corporation human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Mitsubishi Tanabe Pharma Corporation with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Mitsubishi Tanabe Pharma’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Mitsubishi Tanabe Pharma Corporation’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Mitsubishi Tanabe Pharma Corporation in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Mitsubishi Tanabe Pharma Corporation’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Mitsubishi Tanabe Pharma Corporation.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Mitsubishi Tanabe Pharma Corporation and identify potential opportunities in those areas.

Keyword

Current R&D Portfolio of Mitsubishi Tanabe Pharma Corporation; Mitsubishi Tanabe Pharma Corporation - Key Therapeutics; Mitsubishi Tanabe Pharma Corporation - Pipeline Overview and Promising Molecules; Mitsubishi Tanabe Pharma Corporation - News; Mitsubishi Tanabe Pharma Corporation - Latest Updates; Mitsubishi Tanabe Pharma Corporation - Pipeline; Mitsubishi Tanabe Pharma Corporation - Discontinued/Dormant Projects

To view the detailed table of contents for this report please visit: http://www.reportstack.com/product/67547/mitsubishi-tanabe-pharma-corporation-product-pipeline-review-2012.html